

Sirolimus Drug + PLGA Coating + Cobalt Chromium…….
• Sirolimus drug minimizes chances of restenosis and has a long-term proven efficacy.
• CoCr DES with thin struts of 58 μm for superior Deliverability in challenging tortuous lesions.
• 9 Crown Design to provide excellent trackability of the stent in following the natural bio-mechanics of the artery.
• The biocompatible PLGA Polymer provides consistent, controlled and a 100% drug release.The Polymer degrades 100 % into carbon dioxide and water
leading solutions for the treatment of coronary and neurovascular diseases.